Celldex Therapeutics, Inc. (CLDX)
$29.89+2.01%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2.0B
- Beta
- 0.90
- P/E (TTM)
- -7.11
- Short % float
- 17.94%
- Days to cover
- 3.8
- SI change
- +22.9%
- 1W
- -5.56%
- 1M
- -21.55%
- vs SPY 1W
- -6.72%
- vs SPY 1M
- -24.54%
Industry peers
FMP comparable companies · ranked by market cap
- SYRESELLSpyre Therapeutics, Inc.$8.1BCRISISQ 10$93.19+7.25%
- ABCLBUYAbCellera Biologics Inc.$4.2BCRISISQ -6$13.74+4.41%
- HRMYSELLHarmony Biosciences Holdings, Inc.$2.3BBEARQ 1$39.64+1.72%
- VERASELLVera Therapeutics, Inc.$2.2BCRISISQ 21$30.42+0.50%
- IMNMSELLImmunome, Inc.$2.0BCRISISQ 18$20.90+1.24%
- BHVNSELLBiohaven Ltd.$1.9BCRISISQ 17$12.87+1.26%
- NUVBSELLNuvation Bio Inc.$1.8BCRISISQ 4$5.14+1.01%
- QURESELLuniQure N.V.$1.6BCRISISQ 17$23.46+0.22%
- JANXBUYJanux Therapeutics, Inc.$1.0BRECOVERYQ 12$16.93-0.59%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
